Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation Protocol for The Clinical Use of Convalescent Plasma for Hospitalized Patients With COVID-19. A Prospective Study at a Hospital in Southern Brazil.

NCT05077930 is registered in ClinicalTrials.gov with Tânia Portella Costa as lead sponsor.

NCT NCT05077930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05077930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation Protocol for The Clinical Use of Convalescent Plasma for Hospitalized Patients With COVID-19. A Prospective Study at a Hospital in Southern Brazil.
Lead sponsor
Tânia Portella Costa
Phase
Phase 2
Overall status
Completed
Start date
January 6, 2022
Completion date
April 7, 2022
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

convalescent plasma, coronavirus infections, covid-19, pneumonia, respiratory tract diseases, sars-cov-2